Next Generation Sequencing (NGS) Informatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The Next Generation Sequencing (NGS) Informatics Market was valued at USD 5.48 Billion in 2024, and is expected to reach USD 18.74 Billion by 2030, rising at a CAGR of 22.74%. The market is witnessing substantial growth due to the increasing incidence of cancer and expanding clinical applications of NGS. In 2020, the Global Cancer Observatory recorded over 19 million new cancer cases, with breast, lung, colorectal, prostate, and stomach cancers being the most common. Contributing to market expansion are the rising number of DNA sequencing samples, declining sequencing costs, government-backed genomic initiatives, and growing adoption of NGS over traditional microarray technologies. As sequencing becomes more affordable and integral to disease diagnosis and treatment, the demand for robust informatics platforms capable of managing, analyzing, and interpreting large-scale genomic data continues to grow.

Key Market Drivers

Rising Adoption of Precision Medicine and Genomic-Based Diagnostics

The widespread integration of precision medicine and genomic diagnostics into clinical workflows is a key driver of the NGS informatics market. By enabling the analysis of entire genetic profiles, NGS facilitates identification of disease-causing mutations and supports individualized treatment strategies. Government-led initiatives such as the NIH’s “All of Us Research Program” reflect this trend, collecting genetic data from over one million participants - over 600,000 of whom had enrolled by 2023.

This surge in data fuels the demand for informatics platforms that can store, process, and interpret high-throughput sequencing information. Additionally, broader insurance coverage for genomic testing in countries like the United States is encouraging greater adoption of NGS technologies in hospitals and clinical labs. According to CMS, spending on NGS-based tests has significantly increased, underlining the growing clinical importance of these tools. As a result, demand for scalable NGS informatics systems that can automate variant analysis and support clinical decisions using AI and ML is accelerating across healthcare systems.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in NGS Informatics

The integration of AI and ML into NGS informatics is revolutionizing genomic data analysis by enabling rapid, accurate, and efficient interpretation of complex datasets. These technologies are embedded into pipelines for variant calling, annotation, and clinical reporting, helping to identify structural rearrangements and polygenic risk scores. Tools like DeepVariant and AlphaFold have improved the interpretation of genomic data in oncology and rare disease diagnostics. Government backing, such as the U.S. National Artificial Intelligence Initiative and the EU’s Horizon Europe program, underscores global efforts to integrate AI in biomedical research. AI models also enhance the utility of genomic data when integrated with electronic health records, enabling personalized, evidence-based treatment recommendations. As these models become increasingly sophisticated and validated, they are expected to become central to commercial NGS informatics solutions, supporting the broader implementation of precision medicine.

Key Market Players

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN N.V.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

Report Scope:

In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Product & Services:

• Storage and Computing Tools
• Commercial Data Analysis
• Data Interpretation and Reporting Tools
• Next Generation Sequencing (NGS) Informatics Services
• Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

• Drug Discovery
• Genetic Screening
• Disease Diagnosis
• Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

• North America
• United States
• Mexico
• Canada
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• India
• South Korea
• Japan
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.